Reentry tachycardia in children

• Verfasst von: Hien, Maximilian [VerfasserIn]
• Verfasst von: Benito Castro, Fernando [VerfasserIn]
• Verfasst von: Fournier, Philippe [VerfasserIn]
• Verfasst von: Filleron, Anne [VerfasserIn]
• Verfasst von: Tran, Tu-Anh [VerfasserIn]
• Titel: Reentry tachycardia in children
• Titelzusatz: adenosine can make it worse
• Verf.angabe: Maximilian D. Hien, MD, Fernando Benito Castro, MD, Philippe Fournier, MD, Anne Filleron, MD, and Tu-Anh Tran, PhD
• E-Jahr: 2018
• Jahr: December 2018
• Umfang: 4 S.
• Fussnoten: Gesehen am 14.01.2020
• Titel Quelle: Enthalten in: Pediatric emergency care
• Ort Quelle: Philadelphia, Pa. : Lippincott Williams & Wilkins, 1985
• Jahr Quelle: 2018
• Band/Heft Quelle: 34(2018), 12, Seite e239-e242
• ISSN Quelle: 1535-1815
• DOI: doi:10.1097/PEC.0000000000000951
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1687307237

Abstract

Objectives We report on a rare but severe complication of adenosine use in a child with reentry tachycardia. - Methods and Results Treatment with adenosine, which is the standard medical therapy of atrioventricular reentry tachycardia, led to the development of an irregular wide complex tachycardia, caused by rapid ventricular response to atrial fibrillation. The girl was finally stabilized with electrical cardioversion. We analyze the pathomechanism and discuss possible treatment options. - Conclusions Atrial fibrillation, as well as its conduction to the ventricles, can be caused by adenosine. Rapid ventricular response in children with Wolff-Parkinson-White syndrome is more frequent than previously believed. A patient history of atrial fibrillation is a contraindication for cardioversion with adenosine and needs to be assessed in children with reentry tachycardia. High-risk patients may potentially profit from prophylactic comedication with antiarrhythmic agents, such as flecainide, ibutilide, or vernakalant, before adenosine administration.